Brevan Howard Capital Management’s TG Therapeutics TGTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.16M	Buy	60,120 +16,047	+36%	+$578K	0.01%	623
2025 Q1	$1.74M	Buy	44,073 +29,031	+193%	+$1.14M	0.02%	299
2024 Q4	$453K	Buy	+15,042	New	+$453K	﹤0.01%	622
2024 Q3	–	Sell	-53,190	Closed	-$946K	–	1385
2024 Q2	$946K	Buy	+53,190	New	+$946K	0.01%	348